Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pair chart test for an early survival difference.

Guosheng Yin1, Donglin Zeng

  • 1Department of Biostatistics, M. D. Anderson Cancer Center, The University of Texas, Texas, USA. gyin@odin.mdacc.tmc.edu

Lifetime Data Analysis
|March 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimum noninferiority dose for phase I clinical trials with immunotherapy.

Biometrics·2026
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

SEMIPARAMETRIC ANALYSIS OF INTERVAL-CENSORED DATA SUBJECT TO INACCURATE DIAGNOSES WITH A TERMINAL EVENT.

The annals of applied statistics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Asymptotic Inference for Multi-Stage Stationary Treatment Policy with Variable Selection.

Journal of machine learning research : JMLR·2026
Same author

Data fusion methods for the heterogeneity of treatment effect and confounding function.

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability·2026
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

The proposed early difference test offers higher statistical power than the log-rank test for clinical trials where treatments show early effectiveness. This new method improves detection of survival differences, especially when survival curves cross.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Survival Analysis

Background:

  • The log-rank test is standard for comparing survival distributions in clinical trials.
  • It exhibits low statistical power when treatment effects are transient or survival curves cross.
  • Early treatment effectiveness is often crucial but challenging to detect with existing methods.

Purpose of the Study:

  • To propose a novel test statistic for detecting early differences in survival distributions.
  • To enhance statistical power in clinical trials with transient treatment effects.
  • To provide a geometrically intuitive method for analyzing survival data.

Main Methods:

  • Development of a new test statistic with a geometric interpretation using pair charts.
  • Evaluation of the proposed test's power compared to the log-rank test via simulation studies.

Related Experiment Videos

  • Application of the new method to a real-world clinical dataset of gastric cancer patients.

    • Main Results:

    • The proposed test demonstrates superior statistical power over the log-rank test when treatment effects are concentrated in the early study phase.
    • Simulation studies confirm the advantage for finite sample sizes.
    • The method provides a practical approach for identifying early survival benefits.

    Conclusions:

    • The novel test statistic effectively detects early survival differences, outperforming the log-rank test in specific clinical trial scenarios.
    • This method offers a valuable tool for analyzing survival data, particularly when treatment efficacy is time-dependent.
    • The proposed approach enhances the ability to identify beneficial early interventions in clinical research.